News | December 12, 2022
Entod Pharmaceuticals to launch GLO division
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
-0001_256_384.jpg){kind=logo}
The eyecirque under eye skin brightening supplement is a unique composition of scientifically proven essential antioxidants, vitamins and minerals
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
The initiative aims to reach out to more than 20 million people across the country and a number of social media influencers have also pledged to extend their whole-hearted support for the noble cause
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
It is the generic version of molnupiravir
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Subscribe To Our Newsletter & Stay Updated
